Trevi Therapeutics, Inc.

Ownership Transactions Reported by 23 Insiders

Symbol
TRVI on Nasdaq
Industry
Pharmaceutical Preparations
Location
195 Church Street, 14 Th Floor, New Haven, CT

Insiders trading volume in the past year

Trevi Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
New Enterprise Associates 16, L.P. 10%+ Owner $21.1M Apr 11, 2022
Forest Baskett 10%+ Owner $21.1M Apr 11, 2022
Tpg Gp A, Llc Former 10% Owner $7.73M Jul 1, 2022
Ali Behbahani 10%+ Owner $1.92M Apr 11, 2022
Carmen Chang 10%+ Owner $1.92M Apr 11, 2022
Anthony A. Florence Jr. 10%+ Owner $1.92M Apr 11, 2022
Paul Edward Walker 10%+ Owner $1.92M Apr 11, 2022
Peter W. Sonsini 10%+ Owner $1.92M Apr 11, 2022
Scott D. Sandell 10%+ Owner $1.92M Apr 11, 2022
Mohamad Makhzoumi 10%+ Owner $1.92M Apr 11, 2022
David P. Meeker Director $1.03M -$13.4K -1.28% Aug 27, 2024
Thomas Sciascia Chief Scientific Officer $653K -$272K -29.4% Aug 19, 2024
Jennifer L. Good President & CEO, Director $648K -$273K -29.7% Sep 6, 2024
Lisa Delfini Chief Financial Officer $141K -$11.5K -7.55% May 22, 2024
Farrell Simon Chief Commercial Officer $92.2K Feb 15, 2024
Christopher Galletta Controller and Principal Accounting Officer $10.2K Dec 13, 2024
Edward T. Mathers Director Jun 13, 2024
Anne Vanlent Director Jun 13, 2024
Michael Thomas Heffernan Director Jun 13, 2024
Dominick Colangelo Director Jun 13, 2024
William P. Forbes Chief Development Officer Jun 29, 2022
James V. Cassella Chief Development Officer Sep 30, 2024
David J. Clark Chief Medical Officer Feb 15, 2024

Recent Insider Transactions by Companies or Individuals for Trevi Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.